Crosslinkable liquid composition for use in a method of treating an eye disorder
AssigneesUniversiteit Antwerpen, Universitair Ziekenhuis Antwerpen
InventorsBert VAN DEN BOGERD, Sorcha NÍ DHUBHGHAILL
Life of this patent
Estimating the term…
Abstract
The invention relates to a crosslinkable liquid composition comprising: (i) a polyethylene glycol diacrylate (PEGDA), (ii) a gelatin or gelatin-based crosslinkable biomaterial, and (iii) a photoinitiator and optionally a co-initiator, for use in a method of treating an eye disorder in an eye of a subject, wherein the method comprises applying a crosslinkable liquid composition onto an anterior corneal surface of said eye comprising said eye disorder using a mold, crosslinking the crosslinkable liquid composition on the anterior corneal surface of the eye, thereby obtaining a crosslinked composition on the anterior corneal surface of the eye, and correcting the curvature of the crosslinked composition.
Claims18
-12. (canceled)
A method of treating an eye disorder in an eye of a subject in need thereof, the method comprising the steps of:
- applying a crosslinkable liquid composition onto an anterior corneal surface of said eye comprising said eye disorder,
- crosslinking the crosslinkable liquid composition on the anterior corneal surface of the eye, thereby obtaining a crosslinked composition on the anterior corneal surface of the eye, and,
- correcting the curvature of the crosslinked composition,
- wherein the method comprises introducing said crosslinkable liquid composition into a mold which is positioned onto the anterior corneal surface of the eye,
- wherein the eye disorder is a refractive error selected from myopia, hyperopia, astigmatism and presbyopia, and
- wherein the crosslinkable liquid composition comprises:
- a polyethylene glycol diacrylate (PEGDA),
- a gelatin or a gelatin-based crosslinkable biomaterial, and
- a photoinitiator and optionally a co-initiator.
Dependencies are inferred from the claim text.